Disclosure 0001992260-26-000009-6

SEC FORM 4

$1,420,602.66

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 13,309 shares at $106.74 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Dianthus Therapeutics, Inc. /DE/ (DNTH)." Disclosed 2026-09-03. https://desqlong.com/cards/0001992260-26-000009-6 (retrieved 2026-09-26).